These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33622380)

  • 1. Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis.
    Erstad BL; Barletta JF
    Crit Care; 2021 Feb; 25(1):77. PubMed ID: 33622380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium.
    Erstad BL; Barletta JF
    Crit Care; 2020 Jun; 24(1):315. PubMed ID: 32513237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.
    Ross EL; Heizer J; Mixon MA; Jorgensen J; Valdez CA; Czaja AS; Reiter PD
    Am J Health Syst Pharm; 2015 Apr; 72(7):542-56. PubMed ID: 25788508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in hemodynamic resuscitation of the obese critically ill septic shock patient.
    Adams C; Tucker C; Allen B; McRae A; Balazh J; Horst S; Johnson D; Ferreira J
    J Crit Care; 2017 Feb; 37():219-223. PubMed ID: 27969574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
    Lewis TC; Cortes J; Altshuler D; Papadopoulos J
    J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E; Grau S; Luque S; Castillo-Mafla MP; Suárez-de-la-Rica A; Montero-Feijoo A; Salgado P; Gimenez MJ; García-Bernedo CA; Gilsanz F; Roberts JA
    Crit Care; 2018 Apr; 22(1):94. PubMed ID: 29655372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls and pearls with drug dosing in the critically ill obese patient: 10 statements to guide ICU practitioners.
    Barletta JF; Erstad BL
    J Crit Care; 2022 Oct; 71():154105. PubMed ID: 35777217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK; Hughes DW; Attridge RL
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.
    Stelfox HT; Brundin-Mather R; Soo A; Parsons Leigh J; Niven DJ; Fiest KM; Doig CJ; Zuege DJ; Kushner B; Clement F; Straus SE; Cook DJ; Bagshaw SM; Sauro KM
    Intensive Care Med; 2019 Feb; 45(2):211-222. PubMed ID: 30707246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship.
    Blum S; Cunha CB; Cunha BA
    Surg Infect (Larchmt); 2019 Sep; 20(6):439-443. PubMed ID: 31112072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug dosing in hospitalized obese patients with COVID-19.
    Barletta JF; Erstad BL
    Crit Care; 2022 Mar; 26(1):60. PubMed ID: 35287690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unanswered questions about VTE prophylaxis in critically ill obese patients.
    Antigua AD; Voils SA
    Intensive Care Med; 2016 Sep; 42(9):1506-7. PubMed ID: 27412435
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
    Walker CK; Sandmann EA; Horyna TJ; Gales MA
    Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peri-operative Medication Dosing in Adult Obese Elective Surgical Patients: A Systematic Review of Clinical Studies.
    Hussain Z; Curtain C; Mirkazemi C; Zaidi STR
    Clin Drug Investig; 2018 Aug; 38(8):673-693. PubMed ID: 29855999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Guidance for Antibiotic Dosing in Obese Adults.
    Meng L; Mui E; Holubar MK; Deresinski SC
    Pharmacotherapy; 2017 Nov; 37(11):1415-1431. PubMed ID: 28869666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
    Polso AK; Lassiter JL; Nagel JL
    J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of obesity on safety and efficacy of weight-based norepinephrine dosing in septic shock: A single-center, retrospective study.
    Wong PJ; Pandya KA; Flannery AH
    Intensive Crit Care Nurs; 2017 Aug; 41():104-108. PubMed ID: 28343834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.